Literature DB >> 25196266

Developmental outcomes in young children born to mothers with West Nile illness during pregnancy.

Patricia A Sirois1, Gabriella Pridjian, Scott McRae, Alison F Hinckley, Sonja A Rasmussen, Patricia Kissinger, Pierre Buekens, Edward B Hayes, Daniel R O'Leary, Kenneth F Swan, Xu Xiong, Dawn M Wesson.   

Abstract

BACKGROUND: West Nile virus (WNV) infection is associated with acute morbidity and mortality in adults and children. Information on the effects of maternal WNV illness during pregnancy on early childhood development is limited. This study was designed to examine the relationship between maternal WNV illness during pregnancy and birth and developmental outcomes at age 3 years.
METHODS: Mother-child participants were identified using a national surveillance registry for women with WNV illness during pregnancy. Maternal and infant health data and relevant family characteristics were obtained through medical record reviews and maternal questionnaires. All infants received ophthalmologic examinations. Child development was evaluated at age 3 years using the Bayley Scales of Infant and Toddler Development-Third Edition (Bayley-III).
RESULTS: As a group, the children's (N = 11) birth weight, head circumference, and infant ophthalmologic examination results were within age expectations; one child was born preterm (gestational age 36 weeks). Mean (SD) age at the time of Bayley-III testing was 36.7 (3.8) months. The group's mean performance on the Bayley-III was at or above age level in all domains, but one child showed a mild delay in the Adaptive domain. The variability observed in this sample (1/53 [1.9%] Domain scores < -2.0 SDs) was consistent with expectations based upon the distribution of Bayley-III Domain scores in the general population.
CONCLUSION: Maternal WNV infection does not appear to be associated with global developmental delays in young children. These results are preliminary, however, and require confirmation in future research.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  West Nile virus; early childhood development; infancy; pregnancy

Mesh:

Year:  2014        PMID: 25196266      PMCID: PMC4573576          DOI: 10.1002/bdra.23297

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  16 in total

Review 1.  Socioeconomic status and child development.

Authors:  Robert H Bradley; Robert F Corwyn
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

Review 2.  The effects of poverty on children.

Authors:  J Brooks-Gunn; G J Duncan
Journal:  Future Child       Date:  1997 Summer-Fall

Review 3.  West Nile virus: a primer for the clinician.

Authors:  Lyle R Petersen; Anthony A Marfin
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

4.  Intrauterine West Nile virus: ocular and systemic findings.

Authors:  Samuel G Alpert; Jacqueline Fergerson; Léon Paul Noël
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

5.  Intrauterine West Nile virus infection--New York, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-12-20       Impact factor: 17.586

Review 6.  Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses.

Authors:  Asher Ornoy; Alexander Tenenbaum
Journal:  Reprod Toxicol       Date:  2006-02-09       Impact factor: 3.143

7.  Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.

Authors:  Daniel R O'Leary; Stephanie Kuhn; Krista L Kniss; Alison F Hinckley; Sonja A Rasmussen; W John Pape; Lon K Kightlinger; Brady D Beecham; Tracy K Miller; David F Neitzel; Sarah R Michaels; Grant L Campbell; Robert S Lanciotti; Edward B Hayes
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

Review 8.  West Nile virus infection: a pediatric perspective.

Authors:  Edward B Hayes; Daniel R O'Leary
Journal:  Pediatrics       Date:  2004-05       Impact factor: 7.124

9.  Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-02-27       Impact factor: 17.586

Review 10.  Virology, pathology, and clinical manifestations of West Nile virus disease.

Authors:  Edward B Hayes; James J Sejvar; Sherif R Zaki; Robert S Lanciotti; Amy V Bode; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  5 in total

1.  Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice.

Authors:  Derek J Platt; Amber M Smith; Nitin Arora; Michael S Diamond; Carolyn B Coyne; Jonathan J Miner
Journal:  Sci Transl Med       Date:  2018-01-31       Impact factor: 17.956

2.  Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy.

Authors:  Gabriella Pridjian; Patricia A Sirois; Scott McRae; Alison F Hinckley; Sonja A Rasmussen; Patricia Kissinger; Pierre Buekens; Edward B Hayes; Dan O'Leary; Stephanie Kuhn; Kenneth F Swan; Xu Xiong; Dawn M Wesson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-05-25

Review 3.  Emerging Viral Infections in Sub-Saharan Africa and the Developing Nervous System: A Mini Review.

Authors:  Angelina Kakooza-Mwesige; Abdul H Mohammed; Krister Kristensson; Sharon L Juliano; Julius J Lutwama
Journal:  Front Neurol       Date:  2018-02-23       Impact factor: 4.003

Review 4.  Studying the effects of emerging infections on the fetus: Experience with West Nile and Zika viruses.

Authors:  Sonja A Rasmussen; Dana M Meaney-Delman; Lyle R Petersen; Denise J Jamieson
Journal:  Birth Defects Res       Date:  2017-03-15       Impact factor: 2.344

5.  Zika Virus Alters the Viscosity and Cytokines Profile in Human Colostrum.

Authors:  Ocilma B de Quental; Eduardo L França; Adenilda C Honório-França; Tassiane C Morais; Blanca E G Daboin; Italla M P Bezerra; Shirley V Komninakis; Luiz C de Abreu
Journal:  J Immunol Res       Date:  2019-11-15       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.